期刊文献+

胃泌素瘤的临床特点分析和诊断方法比较 被引量:10

Clinical Features and Comparison of Diagnostic Methods of Gastrinoma
下载PDF
导出
摘要 背景:胃泌素瘤为一少见的神经内分泌肿瘤,临床诊断困难。目的:总结胃泌素瘤的临床特点,以提高其诊断水平。方法:回顾性分析北京协和医院1983年1月~2006年12月收治的23例胃泌素瘤患者的临床资料。结果:本组患者从出现症状到确诊平均需(5.5±0.9)年,确诊时合并肝转移者占60.9%。临床表现以腹痛(91.3%)、腹泻(78.3%)为主。胃泌素瘤腹泻多为水泻(88.9%),抑酸剂可缓解症状(94.4%)。胃液分析和空腹血清胃泌素测定的诊断敏感性分别为76.9%和45.5%。生长抑素受体显像对胃泌素瘤诊断率较高(90.0%)。胃泌素瘤可同时分泌其他肽类激素,本组胃泌素瘤80%分泌2种以上激素,50%分泌3种激素。结论:胃泌素瘤的腹泻发生率近80%,仅次于最常见的腹痛症状,临床上不容忽视,其特点为水泻,且抑酸剂治疗有效。生长抑素受体显像对胃泌素瘤诊断率较高。 Background: Gastrinoma is a rare neuroendocrine tumor, which is difficult to diagnose in clinical practice. Aims: To summarize the clinical features of gastrinoma, and to increase its diagnosis rate. Methods: Clinical data of 23 patients with gastrinoma admitted from Jan. 1983 to Dec. 2006 in PUMC Hospital were analyzed retrospectively. Results: It took a period of (5.5±0.9) years from initial presentation till confirmation of diagnosis in gastrinoma patients enrolled in this study, and 60.9% of patients had liver metastases when the diagnosis was confirmed. The predominant symptoms of gastrinoma were abdominal pain (91.3%) and diarrhea (78.3%). 88.9% of patients with diarrhea were watery, which could be relieved by acid inhibitors (94.4%). The sensitivities of gastric acid output and fasting serum gastrin measurements were 76.9% and 45.5%, respectively. Somatostatin receptor imaging (SR1) had a high diagnostic sensitivity (90.0%). Other gastrointestinal peptide hormones could also be secreted by gastrinoma, 80% of the tumors secreted more than two kinds of hormone, and 50% of the tumors secreted three kinds of hermone. Conclusions: The occurrence rate of diarrhea in gastrinoma is nearly 80%, just less than the abdominal pain, which is the most common symptom. Diarrhea should be paid more attention in clinical practice. The feature of diarrhea is watery, and acid inhibitors is effective. SRI has a high diagnosis rate in gastrinoma.
出处 《胃肠病学》 2008年第4期220-222,共3页 Chinese Journal of Gastroenterology
关键词 胃泌素瘤 临床特点 诊断 回顾性研究 Gastrinoma Clinical Features Diagnosis Retrospective Studies
  • 相关文献

参考文献8

  • 1Campana D, Piscitelli L, Mazzotta E, et al. Zollinger- Ellison syndrome. Diagnosis and therapy. Minerva Med, 2005, 96 (3): 187-206.
  • 2Nieto JM, Pisegna JR. The role of proton pump inhibitors in the treatment of Zollinger-Ellison syndrome. Expert Opin Pharmacother, 2006, 7 (2): 169-175.
  • 3Ramage JK, Davies AH, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut, 2005, 54 Suppl 4: iv1-iv16.
  • 4Roy PK, Venzon DJ, Shojamanesh H, et al. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore), 2000, 79 (6): 379-411.
  • 5Corleto VD, Annibale B, Gibril F, et al. Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome? Aliment Pharmacol Ther, 2001, 15 (10): 1555-1561.
  • 6Jensen RT. Overview of chronic diarrhea caused by functional neuroendocrine neoplasms. Semin Gastrointest Dis, 1999, 10 (4): 156-172.
  • 7Berna M J, Hoffmann KM, Long SH, et al. Serum gastrin in Zollinger-Ellison syndrome: Ⅱ. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature, evaluation of diagnostic criteria,proposal of new criteria, and correlations with clinical and tumoral features. Medicine (Baltimore), 2006, 85 (6): 331-364.
  • 8Virgolini I, Traub-Weidinger T, Decristoforo C. Nuclear medicine in the detection and management of pancreatic islet-cell tumours. Best Pract Res Clin Endocrinol Metab, 2005, 19 (2): 213-227.

同被引文献132

引证文献10

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部